Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 09, 2024 | May 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 09, 2024 · Filed May 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,007 |
Reported balance
After 2024-05-09 transaction · row 1
1 source rowRow 1 · 2024-05-09 · Grant · Acquired 8,696 · Balance 54,007 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 28,761 |
Reported balance
Holding disclosure · report date 2024-05-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 28,761 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2024 Filed May 13, 2024 20:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-022925 · wk-form4_1715632777.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,007 Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029798 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,311 Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 8,000 | $55.78 | $446,266.40 |
DisclosureSEC source: 0001209191-22-044801 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,825 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $55.78 to $55.785. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:45 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029710 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,825 Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,253 | $67.22 | $84,220.40 |
DisclosureSEC source: 0001209191-21-038571 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,369 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033156 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,622 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033156 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,726 Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 2,839 | $53.16 | $150,921.24 |
DisclosureSEC source: 0001209191-20-058283 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,196 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029721 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,035 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029721 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,817 Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:14 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 4,136 | $60.99 | $252,245.54 |
DisclosureSEC source: 0001209191-19-046826 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,026 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $60.53 to $61.195. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:31 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031395 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,162 Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:51 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031916 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,377 Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:51 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031916 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,412 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035434 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,241 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035434 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,677 Read SEC document |
| March 13, 2017 Filed Apr 12, 2017 21:08 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GiftCommon Stock | 28,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026713 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse as trustee of a revocable trust Disclosed balance after: 28,761 F1 · kind: The reporting person transferred these shares to a revocable trust of which the reporting person's spouse is trustee. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 13, 2017 Filed Apr 12, 2017 21:08 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GiftCommon Stock | 28,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026713 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,133 F1 · kind: The reporting person transferred these shares to a revocable trust of which the reporting person's spouse is trustee. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,238 | $0.00 Strike: $10.74 | $0.00 |
DisclosureSEC source: 0001209191-17-018270 · doc4.xml · derivative · entry 3 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,238 shares Expires 2017-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the stock options vested every quarter from the grant date of 5/20/2009. F4 · balance_after: This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 5,238 | $43.01 | $225,268.05 |
DisclosureSEC source: 0001209191-17-018270 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,894 F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 5,238 | $10.74 | $56,256.12 |
DisclosureSEC source: 0001209191-17-018270 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.